Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-070385

EVP, Chief Legal Officer sold 41,219 shares at an average $34.24 ($1,411,513)

  • EVP, Chief Legal Officer acquired 40,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Matsuda Masaru EVP, Chief Legal Officer 2026-11-02 Sale 10b5-1 −1,219 $31.86 $38,841 111,289 D: show line 1 in the form
Matsuda Masaru EVP, Chief Legal Officer 2026-11-04 Option exercise 10b5-1 +40,000 $3.64 $145,600 151,289 D: show line 2 in the form
Matsuda Masaru EVP, Chief Legal Officer 2026-11-04 Sale 10b5-1 −40,000 $34.32 $1,372,672 111,289 D: show line 3 in the form
Open-market sales · 41,219 sh · avg $34.24 · $1,411,513

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Matsuda Masaru EVP, Chief Legal Officer 2026-11-04 Option exercise · Stock Option (right to buy) 10b5-1 −40,000 136,000 D: show line 4 in the form
Loading xslF345X06/wk-form4_1793835532.xml…